Engaging new partners to save lives
The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
How do these partnerships find success in the face of seemingly insurmountable challenges?
What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
Where are the opportunities for the next big solutions?
Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
Why should those outside the global health and NGO worlds join this effort?
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
November 12, 2013
Peter Piot, M.D., Ph.D.
Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
Ann M. Veneman, J.D.
Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
Mel Spigelman, M.D.
President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
Kiyoshi Kurokawa, M.D.
Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute
Ko-Yung Tung, J.D.
Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor
333 East 47th Street
New York, NY 10017